Aldose Reductase Involvement in EMT: Emerging Insights and Current Proposed Molecular Mechanisms

Area of Science:

• Biochemistry
• Cell Biology
• Molecular Biology

Background:

• Aldose reductase (AKR1B1) is part of the aldo-keto reductase (AKR) family, involved in metabolic and physiological processes.
• AKR1B1's roles in the polyol pathway and defense against reactive carbonyl species are known, but other functions are unclear.
• Emerging evidence links AKR1B1 expression and activity to epithelial-mesenchymal transition (EMT).

Purpose of the Study:

• To review studies associating AKR1B1 with EMT.
• To analyze proposed molecular mechanisms of AKR1B1 in driving EMT.
• To discuss findings on EMT following AKR1B1 inhibition.

Main Methods:

• Literature review of studies on AKR1B1 and EMT.
• Analysis of proposed molecular mechanisms.
• Discussion of experimental results from AKR1B1 inhibition studies.

Main Results:

• AKR1B1 is a potent promoter of EMT in both tumor and non-tumor contexts.
• The precise molecular mechanisms by which AKR1B1 drives EMT are still under investigation.
• Inhibition of AKR1B1 has shown effects on EMT responses.

Conclusions:

• AKR1B1 plays a significant role in promoting EMT.
• Further research is needed to fully understand the molecular mechanisms and therapeutic potential of targeting AKR1B1 in EMT-related conditions.
• Identifying knowledge gaps is crucial for future research directions.